Abdominal Rectus Diastasis (ARD) Reconstruction

Study acronym: ARD
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 6 more changesShow less
    • Primary completion moved earlier from Dec 31, 2027 to May 31, 2027
    • Study completion pushed from Dec 31, 2027 to May 31, 2029
    • Enrollment target: estimated 110 to confirmed 108
    • Eligibility criteria shortened, about 20 words
    • Secondary endpoints: details revised at 3 of 4 entries
    • Site details revised
  2. Re-verified, no change to tracked fieldsv4
  3. Eligibility criteria expanded, about 9 words
    • Secondary endpoints revised (4)
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to investigate whether abdominal wall reconstruction through laparoscopic surgery can be recommended as a safe treatment alternative for patients with symptomatic rectus diastasis, and if this type of treatment leads to improved quality of life, trunk stability and reduced pain.
Trial Details
NCT Number NCT04182412
Lead Sponsor Karolinska Institutet
Conditions
(from sponsor)		 Rectus Diastasis
Enrollment 108 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov